Clinical trials: Anthracycline-induced Cardiotoxicity

Anthracycline-induced Cardiotoxicity

Preventing Cardiac Sequelae in Pediatric Cancer Survivors

• Completed
• Age: Up to 18 years
• Observational study

Cancer therapy can place childhood cancer survivors at increased risk for heart disease which can lead to significant illness or early death.

Trial name

PCS2 (NCT01805778)

Where

6 sites in United States, Canada

Volunteers

1,128 people

Sponsor

The Hospital for Sick Children